Montreal Gazette
🏢 Postmedia
📍 ON
May 21, 2026
· 1 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Phoenix and Raven Become First Canadian Telehealth Platforms to Offer Generic Semaglutide Direct to Patients
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · RIGHT
ML v2 (DistilBERT)
0.262 · RIGHT
Ensemble
0.131 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.054
2,788 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Eligible Canadians can now access Health Canada–approved generic semaglutide directly, by prescription, starting at $124.99 TORONTO — Today, Phoenix and Raven, leading Canadian digital health providers, announced the launch of generic semaglutide for direct-to-patient access in Canada, making them the first telehealth platform in the country to bring this medication to customers. Phoenix and Raven...
Read full article at Montreal Gazette ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1
Jun 2, 2026
📰
🔒 Unlock — Starter+
1 outlet covered this story
Side-by-side comparison · bias by outlet · framing analysis